Autor segons l'article: Jara-Palomares L, Otero R, Jiménez D, Praena-Fernández JM, Rivas A, Font C, Wells PS, López-Reyes R, González-Martínez J, Monreal M
Departament: Medicina i Cirurgia
Autor/s de la URV: Porras Ledantes, Jose Antonio
Paraules clau: Venous thromboembolism Sex Pulmonary embolism Neoplasm Deep vein thrombosis sex pulmonary embolism neoplasm deep vein thrombosis
Resum: In patients with venous thromboembolism (VTE), male sex has been associated with an increased risk of occult cancer. The influence of sex on clinical characteristics, treatment, cancer sites, and outcome has not been thoroughly investigated yet. We used the Registro Informatizado Enfermedad TromboEmbólica registry to compare the clinical characteristics, treatment strategies, cancer sites, and clinical outcomes in patients with VTE having occult cancer, according to sex. As of June 2014, 5864 patients were recruited, of whom 444 (7.6%; 95% confidence interval: 6.8-8.2) had occult cancer. Of these, 246 (55%) were men. Median time elapsed from VTE to occult cancer was 4 months (interquartile range: 2-8.4), with no sex differences. Women were older, weighed less, and were less likely to have chronic lung disease than men. The most common cancer sites were the lung (n = 63), prostate (n = 42), and colorectal (n = 29) in men and colorectal (n = 38), breast (n = 23), uterine (n = 18), hematologic (n = 17), or pancreas (n = 15) in women. Men were more likely to have lung cancer than women (2.18% vs 0.30%; P < .01) and less likely to have pancreatic cancer (0.17% vs 0.5%; P = .03). Interestingly, breast cancer was more likely found in women aged ?50 years than in those aged <50 years (0.97% vs 0.14%; P = .03). This study highlights the existence of sex differences in patients with VTE having occult cancer. One in every 2 men had lung, prostate, or colorectal cancer. In women, there is a heterogeneity of cancer sites, increasing risk of breast cancer in those aged >50 years.
Àrees temàtiques: Peripheral vascular disease Medicine (miscellaneous) Medicina iii Medicina ii Medicina i Interdisciplinar Hematology General medicine Farmacia Educação física Ciências biológicas ii
Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
ISSN: 10760296
Adreça de correu electrònic de l'autor: joseantonio.porras@urv.cat
Identificador de l'autor: 0000-0001-6418-1822
Data d'alta del registre: 2024-09-07
Versió de l'article dipositat: info:eu-repo/semantics/publishedVersion
Enllaç font original: https://journals.sagepub.com/doi/10.1177/1076029617711805
URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
Referència a l'article segons font original: Clinical And Applied Thrombosis-Hemostasis. 24 (3): 1076029617711805-1076029617711805
Referència de l'ítem segons les normes APA: Jara-Palomares L, Otero R, Jiménez D, Praena-Fernández JM, Rivas A, Font C, Wells PS, López-Reyes R, González-Martínez J, Monreal M (2018). Sex Differences in Patients With Occult Cancer After Venous Thromboembolism.. Clinical And Applied Thrombosis-Hemostasis, 24(3), 1076029617711805-1076029617711805. DOI: 10.1177/1076029617711805
DOI de l'article: 10.1177/1076029617711805
Entitat: Universitat Rovira i Virgili
Any de publicació de la revista: 2018
Tipus de publicació: Journal Publications